New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|May 1, 1997
Supplements and Featured Publications
- Inflammatory Bowel Disease: A Managed Care Perspective
- Volume 3
- Issue 6 Suppl
Inflammatory Bowel Disease: Ulcerative Colitis
Advertisement
Articles in this issue
over 29 years ago
Goals and Objectivesover 29 years ago
Introductionover 29 years ago
Inflammatory Bowel Disease: Crohn's Diseaseover 29 years ago
Selected Abstractsover 29 years ago
CME Quizover 29 years ago
ParticipantsAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement